Documents
Application Sponsors
NDA 022015 | BAYER HEALTHCARE LLC | |
Marketing Status
Application Products
001 | FOR SOLUTION;ORAL | 17GM/SCOOPFUL | 1 | MIRALAX | POLYETHYLENE GLYCOL 3350 |
FDA Submissions
TYPE 8; Type 8 - Partial Rx to OTC Switch | ORIG | 1 | AP | 2006-10-06 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 2 | AP | 2008-11-20 | N/A |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 3 | AP | 2008-12-02 | N/A |
LABELING; Labeling | SUPPL | 6 | AP | 2010-05-05 | STANDARD |
LABELING; Labeling | SUPPL | 12 | AP | 2012-03-15 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 16 | AP | 2013-01-04 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 17 | AP | 2013-10-22 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 18 | AP | 2015-09-24 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 19 | AP | 2014-03-05 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 20 | AP | 2014-08-03 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 22 | AP | 2015-07-14 | STANDARD |
LABELING; Labeling | SUPPL | 23 | AP | 2015-10-29 | STANDARD |
LABELING; Labeling | SUPPL | 24 | AP | 2015-11-12 | STANDARD |
LABELING; Labeling | SUPPL | 25 | AP | 2016-09-30 | STANDARD |
LABELING; Labeling | SUPPL | 26 | AP | 2016-10-21 | STANDARD |
LABELING; Labeling | SUPPL | 27 | AP | 2017-10-04 | STANDARD |
LABELING; Labeling | SUPPL | 29 | AP | 2018-04-24 | STANDARD |
LABELING; Labeling | SUPPL | 30 | AP | 2018-05-04 | STANDARD |
LABELING; Labeling | SUPPL | 33 | AP | 2018-08-17 | STANDARD |
LABELING; Labeling | SUPPL | 34 | AP | 2018-10-12 | STANDARD |
LABELING; Labeling | SUPPL | 35 | AP | 2019-06-03 | STANDARD |
LABELING; Labeling | SUPPL | 40 | AP | 2021-04-27 | STANDARD |
LABELING; Labeling | SUPPL | 43 | AP | 2022-07-05 | STANDARD |
Submissions Property Types
SUPPL | 6 | Null | 6 |
SUPPL | 12 | Null | 7 |
SUPPL | 16 | Null | 0 |
SUPPL | 17 | Null | 0 |
SUPPL | 18 | Null | 0 |
SUPPL | 19 | Null | 0 |
SUPPL | 20 | Null | 0 |
SUPPL | 22 | Null | 0 |
SUPPL | 23 | Null | 6 |
SUPPL | 24 | Null | 6 |
SUPPL | 25 | Null | 6 |
SUPPL | 26 | Null | 7 |
SUPPL | 27 | Null | 15 |
SUPPL | 29 | Null | 7 |
SUPPL | 30 | Null | 15 |
SUPPL | 33 | Null | 7 |
SUPPL | 34 | Null | 7 |
SUPPL | 35 | Null | 15 |
SUPPL | 40 | Null | 7 |
SUPPL | 43 | Null | 6 |
CDER Filings
BAYER HEALTHCARE LLC
cder:Array
(
[0] => Array
(
[ApplNo] => 22015
[companyName] => BAYER HEALTHCARE LLC
[docInserts] => ["",""]
[products] => [{"drugName":"MIRALAX","activeIngredients":"POLYETHYLENE GLYCOL 3350","strength":"17GM\/SCOOPFUL","dosageForm":"FOR SOLUTION;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"Yes","rs":"Yes"}]
[labels] => [{"actionDate":"06\/03\/2019","submission":"SUPPL-35","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/022015Orig1s035lbl.pdf\"}]","notes":""},{"actionDate":"10\/12\/2018","submission":"SUPPL-34","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/022015Orig1s034Lbl.pdf\"}]","notes":""},{"actionDate":"08\/17\/2018","submission":"SUPPL-33","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/022015Orig1s0333Lbl.pdf\"}]","notes":""},{"actionDate":"05\/04\/2018","submission":"SUPPL-30","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/022015Orig1s030lbl.pdf\"}]","notes":""},{"actionDate":"04\/24\/2018","submission":"SUPPL-29","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/022015Orig1s029lbl.pdf\"}]","notes":""},{"actionDate":"10\/04\/2017","submission":"SUPPL-27","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/022015Orig1s027lbl.pdf\"}]","notes":""},{"actionDate":"10\/21\/2016","submission":"SUPPL-26","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/022015Orig1s026lbl.pdf\"}]","notes":""},{"actionDate":"09\/30\/2016","submission":"SUPPL-25","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/022015Orig1s025lbl.pdf\"}]","notes":""},{"actionDate":"11\/12\/2015","submission":"SUPPL-24","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/022015Orig1s024lbl.pdf\"}]","notes":""},{"actionDate":"10\/29\/2015","submission":"SUPPL-23","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/022015Orig1s023lbl.pdf\"}]","notes":""},{"actionDate":"08\/03\/2014","submission":"SUPPL-20","supplementCategories":"Manufacturing (CMC)","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/022015Orig1s020lbl.pdf\"}]","notes":"This supplement type does not usually require new labeling."}]
[originalApprovals] => [{"actionDate":"MIRALAX","submission":"POLYETHYLENE GLYCOL 3350","actionType":"17GM\/SCOOPFUL","submissionClassification":"FOR SOLUTION;ORAL","reviewPriority":"Over-the-counter","inserts":"[]","notes":">Yes"}]
[supplements] =>
[actionDate] => 2019-06-03
)
)